proline has been researched along with imatinib mesylate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhatia, R; Chu, S; Holtz, M; Niu, N; Ramaraj, P; Singh, H; Yee, JK | 1 |
Camelo-Santos, J; de Paula Silveira-Lacerda, E; do Prado Barbosa, A; Guillo, LA | 1 |
Adler, J; Bryansker Kraitshtein, Z; Keshet, R; Reuven, N; Shanzer, M; Shaul, Y | 1 |
3 other study(ies) available for proline and imatinib mesylate
Article | Year |
---|---|
Effect of mutational inactivation of tyrosine kinase activity on BCR/ABL-induced abnormalities in cell growth and adhesion in human hematopoietic progenitors.
Topics: Actins; Animals; Antigens, CD34; Antineoplastic Agents; Benzamides; Cell Adhesion; Cell Division; Cell Movement; Cell Transformation, Neoplastic; Cells, Cultured; Chemokine CXCL12; Chemokines, CXC; Chemotaxis; Fibronectins; Fusion Proteins, bcr-abl; Gene Deletion; Genetic Vectors; Hematopoietic Stem Cells; Humans; Imatinib Mesylate; Mice; Mutation; Piperazines; Proline; Protein-Tyrosine Kinases; Pyrimidines | 2004 |
Arginine homozygosity in codon 72 of p53 correlates with failure to imatinib response in chronic myeloid leukemia.
Topics: Adult; Alleles; Antineoplastic Agents; Arginine; Benzamides; Codon; Female; Genetic Predisposition to Disease; Genotype; Heterozygote; Homozygote; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Polymorphism, Genetic; Proline; Pyrimidines; Tumor Suppressor Protein p53 | 2013 |
c-Abl tyrosine kinase promotes adipocyte differentiation by targeting PPAR-gamma 2.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Benzamides; HEK293 Cells; Humans; Imatinib Mesylate; Mice; Mutation, Missense; NIH 3T3 Cells; Phosphorylation; Phosphotyrosine; Piperazines; Point Mutation; Polymorphism, Single Nucleotide; PPAR gamma; Proline; Protein Binding; Protein Interaction Mapping; Protein Isoforms; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Protein Stability; Protein Structure, Tertiary; Proto-Oncogene Proteins c-abl; Pyrimidines; Sequence Homology, Amino Acid; Species Specificity; Transcription, Genetic | 2014 |